Persistence of furan-induced epigenetic aberrationsin the livers of F344 RATS

Toxicological Sciences

Volumn 144, Issue 2, 2015, Pages 217-226

  De Conti, Aline ^a   Kobets, Tetyana ^a   Tryndyak, Volodymyr ^a   Burnett, Sarah D ^a   Han, Tao ^a   Fuscoe, James C ^a   Beland, Frederick A ^a   Doerge, Daniel R ^a   Pogribny, Igor P ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Gene expression profiling; Genetic toxicology; Liver carcinogenesis; Microarrays

Indexed keywords

FURAN; FURAN DERIVATIVE; HISTONE; LYSINE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CALCIUM SIGNALING; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; EPIGENETICS; FISCHER 344 RAT; GENE EXPRESSION; GENE EXPRESSION PROFILING; LIVER CARCINOGENESIS; MALE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; RAT; TREATMENT OUTCOME; ACETYLATION; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETIC EPIGENESIS; LIVER; METABOLISM; METHYLATION;

RATTUS;

ACETYLATION; ANIMALS; DNA DAMAGE; EPIGENESIS, GENETIC; FURANS; GENE EXPRESSION PROFILING; HISTONES; LIVER; LYSINE; MALE; METHYLATION; RATS; RATS, INBRED F344;

EID: 84926472665     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfu313     Document Type: Article

References (48)

1. Arita, A., Shamy, M. Y., Chervona, Y., Clancy, H. A., Sun, H. A., Hall, M. N., Qu, Q., Gamble, M. V., and Costa, M. (2012). The effect of exposure to carcinogenic metals on histone tail modifications and gene expression in human subjects. J. Trace Elem. Med. Biol. 26, 174-178.
2. Balatoni, C. E., Dawson, D. W., Suh, J., Sherman, M. H., Sanders, G., Hong, J. S., Frank, M. J., Malone, C. S., Said, J. W., and Teitell, M. A. (2009). Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress. Am. J. Pathol. 175, 1653-1661.
3. Bannasch, P. (1986). Preneoplastic lesions as end point in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis 7, 689-695.
4. Chen, T., Mally, A., Ozden, S., and Chipman, J. K. (2010). Low doses of the carcinogen furan alter cell cycle and apoptosis gene expression in rat liver independent of DNA methylation. Environ. Health Perspect. 118, 1597-1602.
5. Chen, T., Williams, T. D., Mally, A., Hamberger, C., Mirbahai, L., Hickling, K., and Chipman, J. K. (2012). Gene expression and epigenetic changes by furan in rat liver. Toxicology 292, 63-70.
6. Christman, J. K., Sheikhnejad, G., Dizik, M., Abileah, S., and Wainfan, E. (1993). Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis 14, 551-557.
7. Clemente-Ruiz, M., González-Prieto, R., and Prado, F. (2011). Histone H3K56 acetylation, CAF1, and Rtt106 coordinate nucleosome assembly and stability of advancing replication forks. PLoS Genet. 7, e1002376.
8. Conti, A. D., Kobets, T., Escudero-Lourdes, C., Montgomery, B., Tryndyak, V., Beland, F. A., Doerge, D. R., and Pogribny, I. P. (2014). Dose-and time-dependent epigenetic changes in the livers of Fisher344 rats exposed to furan. Toxicol. Sci. 139, 371-380.
9. Dik, S., Scheepers, P. T., and Godderis, L. (2012). Effects of environmental stressors on histone modifications and their relevance to carcinogenesis: a systematic review. Crit. Rev. Toxicol. 42, 491-500.
10. Dillon, N., and Festenstein, R. (2002). Unravelling heterochromatin: competition between positive and negative factors regulates accessibility. Trends Genet. 18, 252-258.
11. Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al.(2011). Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43-49.
12. Fang, H., Harris, S. C., Su, Z., Chen, M., Qian, F., Shi, L., Perkins, R., and Tong, W. (2009). ArrayTrack: an FDA and public genomic tool. Methods Mol. Biol. 563, 379-398.
13. Fetahu, I. S., Höbaus, J., Aggarwal, A., Hummel, D. M., Tennakoon, S., Mesteri, I., Baumgartner-Parzer, S., and Kállay, E. (2014) Calcium-sensing receptor silencing in colorectal cancer is associated with promoter hypermethylation and loss of acetylation on histone 3. Int. J. Cancer 135, 2014-2023.
14. Fransson-Steen, R., Goldsworthy, T. L., Kedderis, G. L., and Maronpot, R. R. (1997). Furan-induced liver cell proliferation and apoptosis in female B6C3F1 mice. Toxicology 118, 195-204.
15. Grewal, S. I. S., and Moazed, D. (2003). Heterochromatin and epigenetic control of gene expression. Science 301, 798-802.
16. Hickling, K. C., Hitchcock, J. M., Oreffo, V., Mally, A., Hammond, T. G., Evans, J. G., and Chipman, J. K. (2010). Evidence of oxidative stress and associated DNA damage, increased proliferative drive, and altered gene expression in rat liver produced by the cholangiocarcinogenic agent furan. Toxicol. Pathol. 38, 230-243.
17. International Agency for Research on Cancer (IARC). (1995). Furan. IARC Monogr. Eval. Carcinog. Risks Hum. 63, 393-407 (IARC, Lyon, France).
18. Jackson, A. F., Williams, A., Recio, L., Waters, M. D., Lambert, I. B., and Yauk, C. L. (2014). Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan. Toxicol. Appl. Pharmacol. 274, 63-77.
19. Kanehisa, M., and Goto, S. (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27-30.
20. Kladde, M. P., and Simpson, R. T. (1994). Positioned nucleosomes inhibit Dam methylation in vivo. Proc. Natl. Acad. Sci. U.S.A. 91, 1361-1365.
21. Kleinstreuer, N. C., Dix, D. J., Houck, K. A., Kavlock, R. J., Knudsen, T. B., Martin, M. T., Paul, K. B., Reif, D. M., Crofton, K. M., Hamilton, K., et al. (2013). In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. Toxicol. Sci. 131, 40-55.
22. Liu, Y., Hong, Y., Zhao, Y., Ismail, T. M., Wong, Y., and Eu, K. W. (2008). Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. Cancer Invest. 26, 575-582.
23. Luo, R. X., and Dean, D. C. (1999). Chromatin remodeling and transcriptional regulation. J. Natl. Cancer Inst. 91, 1288-1294.
24. Maga, J. A. (1979). Furans in foods. CRC Crit. Rev. Food Sci. Nutr. 11, 355-400.
25. Min, L., Ji, Y., Bakiri, L., Qiu, Z., Cen, J., Chen, X., Chen, L., Scheuch, H., Zheng, H., Qin, L., Zatloukal, K., Hui, L., and Wagner, E. F. (2012). Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 14, 1203-1211.
26. Miranda, T. B., Kelly, T. K., Bouazoune, K., and Jones, P. A. (2010). Methylation-sensitive single-molecule analysis of chromatin structure. Curr. Protoc. Mol. Biol. Chapter 21, Unit 21.17.1-21.17.16.
27. Moser, G. J., Foley, J., Burnett, M., Goldsworthy, T. L., and Maronpot, R. (2009). Furan-induced dose-response relationships for liver cytotoxicity, cell proliferation, and tumorigenicity (furan-induced liver tumorigenicity). Exp. Toxicol. Pathol. 61, 101-111.
28. Muzio, G., Maggiora, M., Paiuzzi, E., Oraldi, M., Canuto, R. A. (2012). Aldehyde dehydrogenases and cell proliferation. Free Radic. Biol. Med. 52, 735-746.
29. National Toxicology Program (NTP). (1993). Toxicology and carcinogenesis studies of furan (CAS No. 110-00-9) in F344/N rats and B6C3F1 mice (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 402, 1-77.
30. Okabe, H., Beppu, T., Hayashi, H., Horino, K., Masuda, T., Komori, H., Ishikawa, S., Watanabe, M., Takamori, H., Iyama, K., and Baba, H. (2009). Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Ann. Surg. Oncol. 16, 2555-2564.
31. Perez Locas, C., and Yaylayan, V. A. (2004). Origin and mechanistic pathways of formation of the parent furan: a food toxicant. J. Agric. Food Chem. 52, 6830-6836.
32. Pogribny, I., Yi, P., and James, S. J. (1999). A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem. Biophys. Res. Commun. 262, 624-628.
33. Pogribny, I. P., Ross, S. A., Wise, C., Pogribna, M., Jones, E. A., Tryndyak, V. P., James, S. J., Dragan, Y. P., and Poirier, L. A. (2006). Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutat. Res. 593, 80-87.
34. Powell, C. L., Swenberg, J. A., and Rusyn, I. (2005). Expression of base excision DNA repair genes as a biomarker of oxidative DNA damage. Cancer Lett. 229, 1-11.
35. Recio, L., Phillips, S. L., Maynor, T., Waters, M., Jackson, A. F., and Yauk, C. L. (2013). Differential expression of long noncoding RNAs in the livers of female B6C3F1 mice exposed to the carcinogen furan. Toxicol. Sci. 135, 369-379.
36. Rubinek, T., Shulman, M., Israeli, S., Bose, S., Avraham, A., Zundelevich, A., Evron, E., Gal-Yam, E. N., Kaufman, B., and Wolf, I. (2012). Epigenetic silencing of the tumor suppressor klotho in human breast cancer. Breast Cancer Res. Treat. 133, 649-657.
37. Rusyn, I., Asakura, S., Pachkowski, B., Bradford, B. U., Denissenko, M. F., Peters, J. M., Holland, S. M., Reddy, J. K., Cunningham, M. L., and Swenberg, J. A. (2004). Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res. 64, 1050-1057.
38. Sadikovic, B., Andrews, J., Carter, D., Robinson, J., and Rodenhiser, D. I. (2008). Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF-7 breast cancer cells. J. Biol. Chem. 283, 4051-4060.
39. Schmittgen, T. D., and Livak, K. J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108.
40. Si, J., Boumber, Y. A., Shu, J., Qin, T., Ahmed, S., He, R., Jelinek, J., and Issa, J. P. (2010). Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Res. 70, 6968-6977.
41. Stirzaker, C., Song, J. Z., Davidson, B., and Clark, S. J. (2004). Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 64, 3871-3877.
42. Strauss, W. M. (1989). Preparation of genomic DNA from mammalian tissue. In Current Protocols in Molecular Biology (F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. A. Seidman, J. A. Smith, and K. Struhl, Eds.), pp. 2.2.1-2.2.3. Wiley-Interscience, New York, NY.
43. Takai, D., and Jones, P. A. (2003). The CpG island searcher: a new WWWresource. In Silico Biol. 3, 235-240.
44. Tanaka, A., Tanizawa, H., Sriswasdi, S., Iwasaki, O., Chatterjee, A. G., Speicher, D. W., Lewin, H. L., Noguchi, E., and Noma, K. (2012). Epigenetic regulation of condensing-mediated genome organization during the cell cycle and upon DNA damage through histone H3 lysine 56. Mol. Cell. 48, 532-546.
45. Turner, B. M. (1998). Histone acetylation as an epigenetic determinant of long-term transcriptional competence. Cell. Mol. Life Sci. 54, 21-31.
46. US Food and Drug Administration (US-FDA). (2004). Furan in Food, Thermal Treatment. Available at: www.cfsan.fda.gov/lrd/fr040510.html (last accessed November, 2014).
47. Vaissièe, T., Sawan, C., and Herceg, Z. (2008). Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res. 659, 40-48.
48. Wentzensen, N., Bakkum-Gamez, J. N., Killian, J. K., Sampson, J., Guido, R., Glass, A., Adams, L., Luhn, P., Brinton, L. A., Rush, B., et al. (2014). Discovery and validation of methylation markers for endometrial cancer. Int. J. Cancer 135, 1860-1868.